Aveo Pharmaceuticals (AVEO) is trading 8% higher at $8.76 today. The stock's price action is strongly outperforming it's peers on what is quickly becoming a somewhat pessimistic day for the Health Care sector.


Aveo Pharmaceuticals has been trading between a 52-week high of $9.27 and a 52-week low of $3.06. The stock has a market cap of $303 Million.

AVEO Pharmaceuticals Inc. is an oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for cancer patients. AVEO's strategy is to focus its resources toward the development and commercialization of its product candidates in North America, while leveraging partnerships to support development and commercialization in other geographies.

AVEO Pharmaceuticals Stock: A Current Assessment On (NASDAQ:AVEO)
Seeking Alpha 08-15-22

AVEO Pharmaceuticals, Inc. (AVEO) CEO Michael Bailey on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha 08-04-22

AVEO Pharmaceuticals GAAP EPS of -$0.24 beats by $0.04, revenue of $25.3M misses by $0.17M
Seeking Alpha 08-04-22

AVEO Pharmaceuticals Earnings Preview
Benzinga 08-03-22

AVEO Pharmaceuticals'' (AVEO) CEO Michael Bailey on Q1 2022 Results - Earnings Call Transcript
Seeking Alpha 05-05-22